Decoy Therapeutics Inc, a biotechnology company focused on developing Designable Multi-Antivirals (D-MAVs), has announced that one of its D-MAV candidates has demonstrated in vitro effectiveness against the wild-type Ebola Zaire …
Antibiotics have revolutionized healthcare and played a vital role in saving numerous lives. However, the growing problem of antimicrobial resistance (AMR) is reducing the effectiveness of existing antibiotics. Addressing AMR …
